We evaluated the efficacy of vascular endothelial growth factor 165 (VEGF165) transgenic bone marrow mesenchymal stem cells (BMSCs) for the repair of early-stage osteonecrosis of the femoral head (ONFH) in mature mongrel dogs. This animal model was surgically established by femoral neck osteotomy and subsequent repinning. Twenty-seven dogs (54 hips) were divided into 3 equal-sized groups: a pCI-neo-VEGF165 BMSC group, a pCI-neo BMSC group and a core decompression-alone group. The lipofectamine was used to introduce the VEGF165 gene into the BMSCs. After core decompression, transgenic and non-transgenic autologous BMSCs were implanted. Therapeutic efficacy, including new bone formation and neovascularization in the femoral head, was examined by computed radiography, single-photon emission computed tomography, histological and histomorphometric analysis and immunofluorescent staining for von Willebrand factor in pathological sections. The femoral osteotomy site healed completely by the 4th week after the osteotomy surgery and regions of histologically evident osteonecrosis were found 12 weeks later. A regular arrangement of trabeculae and obvious bone regeneration were observed in the animals receiving implanted VEGF-transgenic BMSCs. The quantity of newly generated capillaries was significantly increased in the pCI-neo-VEGF165 BMSC group, but there was no significant difference between the pCI-neo BMSC group and the core decompression-alone group. These results demonstrated that VEGF165 transgenic autologous BMSCs enhanced bone reconstruction and blood vessel regeneration in the ONFH model. Compared with non-transgenic BMSCs, this approach could provide advanced benefits in the treatment of ONFH.

1.
Allt, G., J.G. Lawrenson (2001) Pericytes: cell biology and pathology. Cells Tissues Organs 169: 1–11.
2.
Baltzer, A.W., J.R. Lieberman (2004) Regional gene therapy to enhance bone repair. Gene Ther 11: 344–350.
3.
Campbell, A.I., Y. Zhao, R. Sandhu, D.J. Stewart (2001) Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension. Circulation 104: 2242–2248.
4.
Capito, R.M., M. Spector (2003) Scaffold-based articular cartilage repair. IEEE Eng Med Biol Mag 22: 42–50.
5.
Compere, E.L., Wallace G. (1942) Etiology of aseptic necrosis of the head of the femur after transcervical fracture. J Bone Joint Surg Am 24: 831–841.
6.
Davidovitch, R.I., C.J. Jordan, K.A. Egol, M.S. Vrahas (2010) Challenges in the treatment of femoral neck fractures in the nonelderly adult. J Trauma 68: 236–342.
7.
Deans, R.J., A.B. Moseley (2000) Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 28: 875–884.
8.
Gangji, V., J.P. Hauzeur, C. Matos, V. De Maertelaer, M. Toungouz, M. Lambermont (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells: a pilot study. J Bone Joint Surg Am 86: 1153–1160.
9.
Gangji, V., J.P. Hauzeur, A. Schoutens, M. Hinsenkamp, T. Appelboom, D. Egrise (2003) Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 30: 348–351.
10.
Gangji, V., M. Toungouz, J.P. Hauzeur (2005) Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther 5: 437–442.
11.
Geiger, F., H. Bertram , I. Berger, H. Lorenz, O. Wall, C. Eckhardt, H.G. Simank, W. Richter (2005) Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20: 2028–2035.
12.
Hernigou, P., F. Beaujean (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res 405: 14–23.
13.
Hernigou, P., F. Beaujean, J.C. Lambotte (1999) Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J Bone Joint Surg Br 81: 349–355.
14.
Jones, E.A., A. English, S.E. Kinsey, L. Straszynski, P. Emery, F. Ponchel, D. McGonagle (2006) Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin Cytom 70: 391–399.
15.
Jones, J.P. (1994) Etiology and pathogenesis of osteonecrosis. Clin J Orthop 14: 153–160.
16.
Hiltunen, M.O., M. Ruuskanen, J. Huuskonen, A.J. Mahonen, M. Ahonen, J. Rutanen, V.M. Kosma, A. Mahonen, H. Kröger, S. Ylä-Herttuala (2003) Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. FASEB J 17: 1147–1149.
17.
Huo, M.H., J. Parvizi, B.S. Bal, M.A. Mont (2008) What’s new in total hip arthroplasty. J Bone Joint Surg Am 91: 2522–2534.
18.
Kaku, M., S. Kohno, T. Kawata, I. Fujita, C. Tokimasa, K. Tsutsui, K. Tanne (2001) Effects of vascular endothelial growth factor on osteoclast induction during tooth movement in mice. J Dent Res 80: 1880–1883.
19.
Keramarisa, N.C., G.M. Calorib, V.S. Nikolaoua, E.H. Schemitschc, P.V. Giannoudisa (2008) Fracture vascularity and bone healing: a systematic review of the role of VEGF. Injury 39(suppl 2): S45–S57.
20.
Kramer, J., G. Scheurecker, A. Scheurecker, A. Stöger, A. Huber, S. Hofmann (2009) Femoral head necrosis. Radiologe 49: 410–418.
21.
Kuo, T.K., J.H. Ho, O.K. Lee (2009) Mesenchymal stem cell therapy for nonmusculoskeletal diseases: emerging applications. Cell Transplant 18: 1013–1028.
22.
Leach, J.K., D. Kaiglerb, Z. Wang, P.H. Krebsbach, D.J. Mooney (2006) Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials 27: 3249–3255.
23.
Lee, J.S., J.S. Lee, H.L. Roh, C.H. Kim, J.S. Jung, K.T. Suh (2006) Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor. J Orthop Res 24: 604–609.
24.
Lee, K., M.K. Majumdar, D. Buyaner, J.K. Hendricks, M.F. Pittenger, J.D. Mosca (2001) Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol Ther 3: 857–866.
25.
Marker, D.R., T.M. Seyler, M.S. McGrath, R.E. Delanois, S.D. Ulrich, M.A. Mont (2008) Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am 90(suppl 4): 175–187.
26.
Matsumoto, R., T. Omura, M. Yoshiyama, T. Hayashi, S. Inamoto, K.R. Koh, K. Ohta, Y. Izumi, Y. Nakamura, K. Akioka, Y. Kitaura, K. Takeuchi, J. Yoshikawa (2005) Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol 25: 1168–1173.
27.
Mont, M.A., L.C. Jones, T.A. Einhorn, D.S. Hungerford, A.H. Reddi (1998) Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors. Clin Orthop Relat Res 355(suppl): S314–S335.
28.
Niemeyer, P., K. Szalay, R. Luginbühl, N.P. Südkamp, P. Kasten (2010) Transplantation of human mesenchymal stem cells in a non-autogenous setting for bone regeneration in a rabbit critical-size defect model. Acta Biomater 6: 900–908.
29.
Parfitt, A.M. (2000) The mechanism of coupling: a role for the vasculature. Bone 26:319–323.
30.
Pelissier, P., F. Villars, S. Mathoulin-Pelissier, R. Bareille, M.H. Lafage-Proust, J. Vilamitjana-Amedee (2003) Influences of vascularization and osteogenic cells on heterotopic bone formation within a madreporic ceramic in rats. Plast Reconstr Surg 111: 932–941.
31.
Petrigliano, F.A., J.R. Lieberman (2007) Osteonecrosis of the hip: novel approaches to evaluation and treatment. Clin Orthop Relat Res 465: 53–62.
32.
Piedimonte, G., R.J. Pickles, J.R. Lehmann, D. McCarty, D.L. Costa, R.C. Boucher (1997) Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflammation. Am J Respir Cell Mol Biol 16: 250–258.
33.
Pittenger, M.F., A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, D.R. Marshak (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147.
34.
Pufe, T., B. Wildemann, W. Petersen, R. Mentlein, M. Raschke, G. Schmidmaier (2002) Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res 309: 387–392.
35.
Schulick, A.H., K.D. Newman, R.Virmani, D.A. Dichek (1995) In vivo gene transfer into injured carotid arteries: optimization and evaluation of acute toxicity. Circulation 91: 2407–2414.
36.
Service, R.F. (2000) Tissue engineers build new bone. Science 289: 1498–1500.
37.
Street, J., M. Bao, L. de Guzman, S. Bunting, F.V. Jr Peale, N. Ferrara, H. Steinmetz, J. Hoeffel, J.L. Cleland, A. Daugherty, N. van Bruggen, H.P. Redmond, R.A. Carano, E.H. Filvaroff (2002) Vascular endothelial growth factor stimulates repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 9656–9661.
38.
Tang, T.T., B. Lu, B. Yue, X.H. Xie, Y.Z. Xie, K.R. Dai, J.X. Lu, J.R. Lou (2007) Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue engineered bone in goats. J Bone Joint Surg Br 89: 127–132.
39.
Tsuchida, H., J. Hashimoto, E. Crawford, P. Manske, J. Lou (2003) Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Orthop Res 21: 44–53.
40.
Varoga, D., W. Drescher, M. Pufe, G. Groth, T. Pufe (2009) Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head. Clin Orthop Relat Res 467: 3273–3282.
41.
Wang, P., X.F. Yao, L.P. Yu, R.C. Dai, J.X. Song (2007) Biomechanics of cancellous bone with avascular necrosis. J Tsing-hua Univ (Sci Tech) 47: 726–729.
42.
Wen, Q., L. Ma, Y.P. Chen, L. Yang, W. Luo, X.N. Wang (2008) Treatment of avascular necrosis of the femoral head by hepatocyte growth factor-transgenic bone marrow stromal stem cells. Gene Ther 15: 1523–1535.
43.
Winstanley, C., R. Rapley (2000) Extraction and purification of plasmid DNA; in Rapley R. (ed): The Nucleic Acid Protocols Handbook. Totowa, Humana Press, vol 45, pp 327–331.
44.
Yan, Z., D. Hang, C. Guo, Z. Chen (2009) Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J Orthop Res 27: 442–446.
45.
Yan, Z.Q., Y.S. Chen, W.J. Li, Y. Yang, J.Z. Huo, Z.R. Chen, J.H. Shi, J.B. Ge (2006) Treatment of osteonecrosis of the femoral head by percutaneous decompression and autologous bone marrow mononuclear cell infusion. Chin J Traumatol 9: 3–7.
46.
Yang, C., S.H. Yang, J.Y. Du, J. Li, W.H. Xu, YF. Xiong (2003) Vascular endothelial growth factor gene transfection to enhance the repair of avascular necrosis of the femoral head of rabbit. Chin Med J (Engl) 116: 1544–1548.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.